QualityStocksNewsBreaks – Why Predictive Oncology Inc. (NASDAQ: POAI) Is ‘One to Watch’
Data and artificial intelligence-driven discovery services company Predictive Oncology (NASDAQ: POAI) provides predictive models of tumor drug response to improve patient outcome. A recent article discussing the company reads, “Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based road map for therapy. . . . In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that…